论文部分内容阅读
作者采用免疫组化法,以血管内皮生长因子受体-3(vascular endothelial growth factor receptor-3,VEGFR-3,又称FLT-4)为标记物,检测乳腺癌组织内微淋巴管密度(microlymphatic density,MLD),研究其与增殖期细胞核抗原
The authors used immunohistochemistry to detect the expression of microlymphatic microvessels in breast cancer tissues using vascular endothelial growth factor receptor-3 (VEGFR-3, also called FLT-4) density, MLD) to study its relationship with proliferating cell nuclear antigen